Dr. Stephen Levine Reflects on 40 Years in Gender Medicine. - Original Rebels Series (#21
10 July 2025
With Stephen B. Levine
North America
Dr. Stephen Levine co-founded one of America's first gender identity clinics in 1974 and later chaired WPATH's fifth Standards of Care committee before leaving the organisation in 2002. In this conversation he reflects on fifty years of clinical practice, explaining how a field that once embraced diagnostic uncertainty became hostile to it. His account bears directly on Ireland: the HSE's gender services operate within a framework built on WPATH guidelines, and the methodological questions he raises — about regret rates, diagnostic speed and the erosion of clinical curiosity — are questions Irish medicine has not yet formally resolved.
Few clinicians alive have as direct a line to the foundations of gender medicine as Dr. Stephen Levine. A Distinguished Life Fellow of the American Psychiatric Association and Clinical Professor of Psychiatry at Case Western Reserve University School of Medicine, he has co-directed one of the earliest gender identity clinics in the United States since 1974 and chaired the fifth Standards of Care committee for what would become WPATH. He left the organisation in 2002, concluding that advocacy had displaced scientific inquiry beyond recovery. This episode documents what Levine observed across those five decades. He describes how early gender clinics operated with genuine intellectual uncertainty, treating patients across a wide range of presentations and following outcomes wherever they led. What replaced that approach, in his account, was institutional pressure to affirm rather than investigate — a shift made visible when professional conferences responded to clinical dissent with booing rather than counter-evidence. One of the most consequential claims he challenges is the widely repeated figure of a two percent regret rate following gender-related procedures. Levine argues this statistic does not withstand scrutiny: it derives from follow-up studies that lost substantial proportions of participants and conflated patient satisfaction with long-term clinical outcome. His question — how many people must be harmed before a treatment intervention is reconsidered — is not rhetorical. It is the oldest question in medical ethics, and he believes the field has ceased asking it. The Irish relevance is direct. The HSE's National Gender Service and the clinical protocols used by Irish practitioners operate within a framework shaped substantially by WPATH's successive Standards of Care. When the assumptions underpinning those standards are challenged by one of the architects of the original framework, Irish clinicians and policymakers are not observing a foreign debate. The methodological concerns Levine has raised for years closely parallel those that drove the Cass Review in Britain, whose findings prompted immediate NHS policy change and reverberated across European healthcare systems. He also addresses what happens to doctors who express uncertainty. Clinicians who decline to affirm a diagnosis rapidly, or who raise questions about comorbidities and other contributing factors, face professional and social consequences the episode documents in some detail. That pressure is not unique to any one country, and Irish practitioners are not insulated from it. What Levine ultimately calls for is modest: the restoration of a clinician's right to say we do not know without that honesty being treated as evidence of hostility. In a field where diagnostic speed has been elevated over diagnostic rigour, and where long-term outcomes remain genuinely uncertain, that demand carries more weight than it might first appear.
